Correction: GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma

Bone Marrow Transplant. 2021 Jan;56(1):298. doi: 10.1038/s41409-020-01037-4.

ATL Working Group of the Japanese Society for Hematopoietic Cell Transplantation:
Koji Kato, Makoto Yoshimitsu, Takashi Ishida, Atae Utsunomiya, Koji Kato, Junji Suzumiya, Tomomi Tobai, Koichi Nakase, Yuichiro Nawa, Takuya Fukushima, Yoshitaka Asakura, Hiroshi Fujiwara, Shinichiro Machida, Yasushi Sawayama, Yoshitaka Inoue, Kazunori Imada, Isao Yoshida, Shigeo Fuji, Satoko Morishima, Shohei Tomori, Tomoki Iemura, Takuya Shimizu, Mari Morita-Fujita

¹ Department of Hematology/Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
² Department of Hematology/Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan. [email protected].
³ Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
⁴ Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan.
⁵ Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
⁶ Department of Hematology, Kumamoto Medical Center, Kumamoto, Japan.
⁷ Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan.
⁸ Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
⁹ Department of Hematology, Toranomon Hospital, Tokyo, Japan.
¹⁰ Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
¹¹ Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
¹² Department of Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
¹³ Research Institute for Radiation Biology and Medicine, Department of Hematology and Oncology, Hiroshima University, Hiroshima, Japan.
¹⁴ Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
¹⁵ Nagoya University Graduate School of Medicine, Nagoya, Japan.

No abstract available

Publication types